network member

University of Rochester Medical Center - Wilmot Cancer Institute

601 Elmwood Avenue, Rochester, NY 14642

About Network Member

Website: University of Rochester Medical Center – Wilmot Cancer Institute

https://www.urmc.rochester.edu

Amy Rovitelli

585-275-6753

Currently Enrolling

HCRN-BRE17-141

An Open Label, Phase II Trial of Pre-operative Neratinib and Endocrine Therapy with Trastuzumab in ER-Positive, HER2-Positive Breast Cancers

Ruth O’Regan

Cancer areas:Breast

Penn State Cancer Institute

University of Illinois Cancer Center

University of Rochester Medical Center - Wilmot Cancer Institute

University of Wisconsin Carbone Cancer Center

See clinicaltrials.gov

Enrollment Closed

HCRN-GU18-343

A Phase 2 Study of CAbozantinib in Combination With AtezolizumaB as NeoAdjuvant Treatment for Muscle-Invasive BladdEr Cancer (ABATE)

Deepak Kilari

Cancer areas:Bladder

Froedtert & the Medical College of Wisconsin

John Theurer Cancer Center at Hackensack Meridian Health

Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine

University of Rochester Medical Center - Wilmot Cancer Institute

Vanderbilt-Ingram Cancer Center

Virginia Commonwealth University

See clinicaltrials.gov

Currently Enrolling

BTCRC-BRE15-024

A phase I/II, single arm, non-randomized study of ribociclib (LEE011), a CDK 4/6 inhibitor in combination with bicalutamide, an androgen receptor (AR) inhibitor, in advanced AR+ triple-negative breast cancer: Big Ten Cancer Research Consortium BTCRC-BRE15-024

Kari Wisinski

Cancer areas:Breast

University of Illinois Cancer Center

University of Rochester Medical Center - Wilmot Cancer Institute

University of Wisconsin Carbone Cancer Center

See clinicaltrials.gov